Healthcare -
Biotechnology - NYSE - US
$ 8.475
2.85 %
$ 487 M
Market Cap
-0.8
P/E
DNA - REVENUE
Revenue DNA - Ginkgo Bioworks Holdings, Inc.
251 M
LAST VALUE
-10.49%
2 YEAR CAGR
20.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR